Navigation Links
Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
Date:8/7/2008

HOPKINTON, Mass., Aug. 7 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE), today announced that they will host a conference call on Thursday, August 14th, 2008 at 9:00am EDT to review the second quarter ending June 30, 2008 and discuss other matters related to the Company.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

To access the conference call, please dial 877-879-6201 for domestic and 719-325-4816 international. The code for this conference call is 4315502. Please dial in 5 to 10 minutes prior to the scheduled start time. A replay of the call will be posted on the Investor Relations section of our website, http://www.alseres.com, within 48 hours following the conference call and will be available through Thursday, August 28th, 2008.

About Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's focus is reflected in several important initiatives. Cethrin, a recombinant- protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including b
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
2. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
3. Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
4. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
5. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
6. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
7. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
8. Alseres Pharmaceuticals, Inc. Raises $5 Million
9. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
10. Cipher Pharmaceuticals announces U.S. distribution and supply agreement with Ranbaxy for CIP-ISOTRETINOIN
11. Pacira Pharmaceuticals, Inc. Adds Experienced CFO James S. Scibetta to Leadership of the Organization

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...Withcoldandfluseasonuponus,it,smoreimportantthanev...onsandavoidillness. ,, "Weneedtobeproactivenoto...lnessifwe,resick,"saidEileenFinerty,RN,MS,CIC(cert...ioncontrolandoccupationalhealthatHospitalforSpecia...Surgeryhasoneofthelowestinfectionratesofanyhospita...
(Date:11/26/2009)...emotional rollercoaster, study finds , ,... fear factor meets the jubilant sports fan. , A...those who root for the winning team -- enjoy the g...atch and victory was in doubt, producing feelings ...Thanksgiving weekend as you,re glued to the TV set...
(Date:11/26/2009)...; Ennis, P.A. is offering free nationwide confiden...th control pills who have suffered a Deep Vein Thr...ttack or other related cardiac issues or had their...1-800-856-6405 or go to the firm’s website a... case evaluation form. , ...
(Date:11/25/2009)...entinelleMedicalInc.,aleadingmanufacturerofbreastM...iteofnewleadingedgeclinicalapplicationsonitsAegis(...logicalSocietyofNorthAmerica(RSNA)annualmeetinginC...cationsleveragetheuniquehighqualityimagesgenerated...multipleimagingmodalitiesformulti-parametricassess...
(Date:11/25/2009)...Business,andPressJoinEfforttoEducate ,, MEMPHI...heNationalBipolarFoundationandtheMedicAlertFoundat...le"program,whichisnowbeingwidelyacceptedasaprevent...tionalBipolarFoundationreceivedaproclamationofendo...rnorofLouisianaMitchLandrieu.TheNationalBipolarFou...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
...a surrounding,published research citing the patien...est medical experts have stumbled onto a startling... research from the World Health,Organization publi...ow doctors using a simple checklist before surgery...
...al Lung Cancer Partnership is pleased to announce ...ital Medical Center the recipient of the 2009 Car...es two years of protected time for new investigato...s of DNA and plays a role in supporting aggressive...
...ring a teleconference on Monday, three experts wil... action iron supplement pill with virtually no gas... energy and nutritional benefits from iron to be a...w.p2binc.com ), a retail sales and marketing compa...
...ovations, a pioneer in,assisting clients to achiev...ce improvement through a device-free remote monito...engthening its management team with the,addition o...GO ) , Christopher Raphaelian, MPH, will lead ...
...oldings,Inc.,s, (NYSE: HRC ) fiscal 2009 first q...February 4, 2009. You are invited to participate ...2009 at 8 a.m. EST. , Earnings Release: Hill-...Wednesday, February 4, 2009. The release will als...
...cedure milestone as the system becomes available i...s the country , , ST. LOUIS, Jan. 16 To date, mo...cer treatment procedures have been conducted using... The TargetScan technology has been shown to accur...
Other Medicine News:Health News:America's Best Hospitals Way Ahead of World Health Organization on Surgical Checklist Use 2Health News:Teleconference on Monday, January 19, Announcing New, Innovative Dual Iron Supplement Now Available Over the Counter 2Health News:Pharos Innovations Strengthens Leadership Team, Informatics Program 2Health News:Pharos Innovations Strengthens Leadership Team, Informatics Program 3Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast 2Health News:Targeted Prostate Cancer Biopsy and Cancer Treatment Earns Acceptance From Nation's Top Prostate Specialists 2
(Date:11/25/2009)...,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Nasda...productsforminimallydisruptivesurgicaltreatmentsfo...allonMonday,November30,2009,at5:30p.m.ET/2:30p.m.P...etoreimbursementfortheCompany,sproductsandwillincl...ndanswersession.Thedial-innumbersare1-877-407-4018...
(Date:11/25/2009)...Nov.25/PRNewswire/--Reportlinker.comannouncesthata...,, PainManagement-GlobalTrends ,, http:...Global-Trends.html ,, Widespreadavailabilityof...headventofnewdrugshaveacceleratedthepaceofgrowthin...rsementstructurecontinuetoshapedemandforservices,d...
(Date:11/25/2009)...eNetherlandsandJOHANNESBURG,November25/PRNewswire/...iscoveryannouncedtoday,thattheyhavesignedacollabor...es. , Pyxis,sworldclasscomputationalchemistry...,sservicedivisiontoprovidemedicinaland,syntheticch...ternationalclientnetwork.iThembaPharmaceuticalsand...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Social class gender and ethnic group determine adolescents sexual affective education 49932 1Social class gender and ethnic group determine adolescents sexual affective education 49932 2Canadian excellence strengthened by extensive adoption of open access 8983 1Canadian excellence strengthened by extensive adoption of open access 8983 2PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 2
...cals (Nasdaq: BCRX ) today announced that the fu...eramivir in patients hospitalized for influenza wa... Dr. Michael G. Ison, Assistant Professor, Divisio...n at Northwestern University Feinberg School of ... Respiratory Viral Infections taking place in Bang...
...national team of,researchers has evaluated the eff... of the knee, and the results have been published ..."Osteoarthritis and Cartilage".,The researchers fo... of,various osteoarthritis treatments. After six m...eived Orthokine therapy experienced significantly ...
Other Medicine Technology:Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 2Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 3Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 4Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections 5New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years 2
MBP 10 MicroPoint Design
Sterilized TowerPack Refill System D200
Tipack (Sterilized) D200
MBP XLPFor Hard-to-Reach Places
Medicine Products: